Correlation Between IShares Genomics and Innovator Loup

Can any of the company-specific risk be diversified away by investing in both IShares Genomics and Innovator Loup at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Genomics and Innovator Loup into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between iShares Genomics Immunology and Innovator Loup Frontier, you can compare the effects of market volatilities on IShares Genomics and Innovator Loup and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Genomics with a short position of Innovator Loup. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Genomics and Innovator Loup.

Diversification Opportunities for IShares Genomics and Innovator Loup

-0.31

Correlation Coefficient

IShares Genomics  Innovator Loup

Very good diversification

The 3 months correlation between IShares and Innovator is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding iShares Genomics Immunology and Innovator Loup Frontier in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovator Loup Frontier and IShares Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Genomics Immunology are associated (or correlated) with Innovator Loup. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovator Loup Frontier has no effect on the direction of IShares Genomics i.e., IShares Genomics and Innovator Loup go up and down completely randomly.

Pair Corralation between IShares Genomics and Innovator Loup

Given the investment horizon of 90 days iShares Genomics Immunology is expected to under-perform the Innovator Loup. But the etf apears to be less risky and, when comparing its historical volatility, iShares Genomics Immunology is 1.51 times less risky than Innovator Loup. The etf trades about -0.1 of its potential returns per unit of risk. The Innovator Loup Frontier is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  5,646  in Innovator Loup Frontier on October 12, 2024 and sell it today you would lose (32.00) from holding Innovator Loup Frontier or give up 0.57% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

iShares Genomics Immunology  vs.  Innovator Loup Frontier

iShares Genomics Imm

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days iShares Genomics Immunology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, IShares Genomics is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Innovator Loup Frontier

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Innovator Loup Frontier are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Innovator Loup may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with IShares Genomics and Innovator Loup

The main advantage of trading using opposite IShares Genomics and Innovator Loup positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Genomics position performs unexpectedly, Innovator Loup can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovator Loup will offset losses from the drop in Innovator Loup's long position.

The idea behind iShares Genomics Immunology and Innovator Loup Frontier pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.